Non-Polar Acids using Gemini 5u C6-Phenyl
LC Conditions
Column
Gemini 5 µm C6-Phenyl 110 Å, LC Column 150 x 4.6 mm, Ea
Brand
Gemini
Part No
00F-4444-E0
Phase Name
C6-Phenyl
Elution Type
Isocratic
Mobile Phase
A: 20mM Potassium Phosphate pH 2.5
B: Methanol
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
35
65
Flow Rate
1.00 mL/min
Temperature
22°C
Detection
UV-Vis Abs.-Variable Wave.(UV) @ (22°C)
Detection Info
Sample Notes
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, Gemini C6-Phenyl 4 x 3.0mm, 10/Pk Part No.: AJ0-7915 - Holder Part No.: KJ0-4282
Order Items Used in This Application
- 1. Naproxen
- 2. Diflunisal
- 3. Indomethacin
- 4. Ibuprofen
-OEChem-05271007422D<br><br> 31 32 0 1 0 0 0 0 0999 V2000<br> 9.5312 1.5068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.5369 -0.5173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.4030 0.9827 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 -0.5173 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0<br> 5.1350 -0.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.8671 -0.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.8671 0.9827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 -0.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 0.9827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 1.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 -1.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7610 -0.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7610 1.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 8.6671 1.0035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.4030 -0.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 8.6671 -0.0381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 10.3991 1.0102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8059 -0.8273 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 -1.1373 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 1.2927 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 2.1027 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6490 -1.5173 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 -2.1373 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8890 -1.5173 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7538 -1.1720 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7538 2.1373 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 9.2028 -0.3502 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 -0.2073 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 10.0912 0.4720 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 10.9372 0.7022 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 10.7070 1.5483 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 14 1 0 0 0 0<br> 1 17 1 0 0 0 0<br> 2 15 1 0 0 0 0<br> 2 28 1 0 0 0 0<br> 3 15 2 0 0 0 0<br> 4 5 1 0 0 0 0<br> 4 11 1 6 0 0 0<br> 4 15 1 0 0 0 0<br> 4 18 1 0 0 0 0<br> 5 8 2 0 0 0 0<br> 5 9 1 0 0 0 0<br> 6 7 2 0 0 0 0<br> 6 8 1 0 0 0 0<br> 6 12 1 0 0 0 0<br> 7 10 1 0 0 0 0<br> 7 13 1 0 0 0 0<br> 8 19 1 0 0 0 0<br> 9 10 2 0 0 0 0<br> 9 20 1 0 0 0 0<br> 10 21 1 0 0 0 0<br> 11 22 1 0 0 0 0<br> 11 23 1 0 0 0 0<br> 11 24 1 0 0 0 0<br> 12 16 2 0 0 0 0<br> 12 25 1 0 0 0 0<br> 13 14 2 0 0 0 0<br> 13 26 1 0 0 0 0<br> 14 16 1 0 0 0 0<br> 16 27 1 0 0 0 0<br> 17 29 1 0 0 0 0<br> 17 30 1 0 0 0 0<br> 17 31 1 0 0 0 0<br>M END
Compound Name
Naproxen
CID
156391
Molecular Formula
C14H14O3
Molecular Weight
230
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
1
Similar Applications
Reversed Phase
Extraction of Acid, Basic, and Neutral Pharmaceuticals from Human Plasma Using Strata-X SPE on Kinetex 2.6 µm PS C18 LC Columns
Kinetex 2.6 µm PS C18 100 Å, LC Column 50 x 2.1 mm, Ea
25609
Reversed Phase
NSAIDs extracted on Strata DE 200uL 96 Well
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
24614
Chiral
Chiral Separation of Naproxen (S) on Lux 5µm i-Amylose-1 in Dichloromethane
Lux 5 µm i-Amylose-1, LC Column 250 x 4.6 mm, Ea
24419
Chiral
Chiral Separation of Naproxen on Lux 5µm i-Amylose-1 in Dichloromethane
Lux 5 µm i-Amylose-1, LC Column 250 x 4.6 mm, Ea
24418
Reversed Phase
Pharmaceutical Mix on Kinetex 1.7 F5 50x2.1mm
Kinetex 1.7 µm F5 100 Å, LC Column 50 x 2.1 mm, Ea
22813
Reversed Phase
Pharmaceutical drug mix using Kinetex 5u C18 100x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
20885
Reversed Phase
KNX 5 Brochure - Pharma mix analysis using Kinetex 5um C18 150x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
20738
Reversed Phase
NSAID's in Human Urine using Kinetex 2.6 µ C8 150 x 2.10 mm on Shimadzu Nexera
Kinetex 2.6 µm C8 100 Å, LC Column 100 x 4.6 mm, Ea
19963
Reversed Phase
Veterinary Drugs in Horse Urine on Kinetex 2.6µm C8 50x4.6mm @ 2.00mL/min
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 4.6 mm, Ea
19473
Reversed Phase
Veterinary Drugs in Horse Urine on Kinetex 2.6µm C8 50x4.6mm @ 1.50mL/min
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 4.6 mm, Ea
19472
Reversed Phase
Veterinary Drugs in Horse Urine on Luna 3µm C8(2) 100x4.6mm
Luna 3 µm C8(2) 100 Å, LC Column 100 x 4.6 mm, Ea
19471
Reversed Phase
Veterinary Drugs in Horse Urine on Luna 3µm C18(2) 100x4.6mm
Luna 3 µm C18(2) 100 Å, LC Column 100 x 4.6 mm, Ea
19467
Reversed Phase
Veterinary Drugs in Horse Urine on Kinetex 2.6µm C18 100x4.6mm
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
19466
Reversed Phase
Veterinary Drugs in Horse Urine on Kinetex 2.6µm C8 100x4.6mm
Kinetex 2.6 µm C8 100 Å, LC Column 100 x 4.6 mm, Ea
19465
Reversed Phase
Veterinary Drugs in Horse Urine on Kinetex 2.6µm PFP 100x4.6mm
Kinetex 2.6 µm PFP 100 Å, LC Column 100 x 4.6 mm, Ea
19464
Reversed Phase
Extraction of Analgesics from Plasma Using Strata X-A on Kinetex 2.6u, C18, 50x2.1mm by LC-UV
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19246
Reversed Phase
Analgesics using Kinetex 2.6µm C18 50 x 2.1mm ID (with KrudKatcher Ultra)
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18541
Reversed Phase
Analgesics using Kinetex 2.6µm C18 50 x 2.1mm ID (without KrudKatcher Ultra)
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18540
Reversed Phase
Luna - Analgesics#2
Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea
16900
Reversed Phase
Analgesics on Luna 5u PFP(2)
Luna 5 µm PFP(2) 100 Å, LC Column 150 x 4.6 mm, Ea
16303
NSAIDs on Onyx C18 (Luna Comparison)
15649
Reversed Phase
Analgesic (non-polar acids) at low pH by Gemini 5um C18
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
15606
Reversed Phase
Naproxen Tablets - USP Method
Synergi 4 µm Fusion-RP 80 Å, LC Column 150 x 4.6 mm, Ea
15004
Reversed Phase
Naproxen Tablets - USP Method
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
15003
Reversed Phase
Analgesics on Hyperclone 5u C8
HyperClone 5 µm MOS (C8) 120 Å, LC Column 150 x 4.6 mm, Ea
14701
Reversed Phase
Extraction of Ibuprofen from Serum on Strata™ X
Luna 5 µm C8(2) 100 Å, LC Column 150 x 4.6 mm, Ea
14454
Reversed Phase
Analgesics on Synergi Polar-RP
Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14250
Reversed Phase
Analgesics on Synergi Hydro-RP
Synergi 4 µm Hydro-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14249
Reversed Phase
Anti-inflammatory/Analgesics
Luna 3 µm C8(2) 100 Å, LC Column 75 x 4.6 mm, Ea
12927
Reversed Phase
Anti-inflammatory/Analgesic Drugs
Luna 3 µm C18(2) 100 Å, LC Column 75 x 4.6 mm, Ea
12903
Reversed Phase
Naproxen - Figure 6a
Luna 3 µm C18(2) 100 Å, LC Column 50 x 4.6 mm, Ea
11078
Reversed Phase
Analgesics as a Probe for Phenyl Selectivity
Luna 5 µm C8(2) 100 Å, LC Column 150 x 4.6 mm, Ea
10903
Reversed Phase
Analgesics as a Probe for Phenyl Selectivity
Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
10902
Reversed Phase
Naproxen
Luna 3 µm C18(2) 100 Å, LC Column 50 x 4.6 mm, Ea
10876
Reversed Phase
Analgesics and Anti-Inflammatories
Prodigy 5 µm Phenyl-3 (PH-3) 100 Å, LC Column 150 x 4.6 mm, Ea
10254
Reversed Phase
Anti-Inflammatory/Analgesic Drug on Prodigy 5 ODS (3)
Prodigy 5 µm ODS-3 100 Å, LC Column 150 x 4.6 mm, Ea
10098
Reversed Phase
Naproxen Oral Suspension - USP Acceptable Modified Method
Luna 5 µm C18(2) 100 Å, LC Column 100 x 4.6 mm, Ea
3283
Reversed Phase
Naproxen Tablets - USP Method
Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea
3282
Reversed Phase
Nonsteroidal Anti-inflammatory
Luna 5 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
1179
Reversed Phase
Analgesics
Aqua 5 µm C18 125 Å, LC Column 150 x 4.6 mm, Ea
1170